Navigation Links
Pharmacyclics to Present and Webcast at Upcoming Life Sciences Investor Conferences
Date:9/3/2009

SUNNYVALE, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated diseases and cancer, today announced that Dr. Glenn Rice, President and COO, will provide a business overview at the following conferences:

-- Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston on Wednesday, September 9th at 3:50 p.m. EDT.

-- Rodman & Renshaw 11th Annual Healthcare Conference at the Palace Hotel in New York on Thursday, September 10th at 12:05 p.m. EDT.

There will be a live webcast of the presentations, which will be accessible through a link posted on the investor relations / events & webcasts section of the PCYC website, please go to http://ir.pharmacyclics.com/events.cfm. The webcasts will be available for replay through October 10th, 2009.

About Pharmacyclics

Pharmacyclics((R)) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune mediated disease and cancer. The purpose of the company is to create a profitable business by generating income from products it develops, licenses and commercializes, either with one or several potential partners or alone as may best forward the economic interest of its stakeholders. The Company endeavors to create novel, patentable, differentiated products that have the potential to significantly improve the standard of care in the markets it serves. Presently, Pharmacyclics has four product candidates in c
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmacyclics, Inc. Rights Offering Oversubscribed
2. Pharmacyclics Announces Subscription Price for Rights Offering
3. Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
4. Pharmacyclics Files Registration Statement for Rights Offering
5. Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
6. Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
7. Pharmacyclics Secures $5.0 Million in Debt Financing
8. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
9. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
10. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
11. Pharmacyclics Announces It Received Nasdaq Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015   California Cryobank Stem Cell Services LLC ... Cryogenics, an east coast cord blood and reproductive tissue ... tristate area. LifeLine clients will maintain full access ... be honored. Since 1991, LifeLine has provided ... sperm, eggs, embryos, and cord blood stem cells. LifeLine Cryogenics ...
(Date:8/3/2015)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the leading ... processes to develop and market advanced products and therapies ... Ophthalmic and Dental sectors of healthcare, announced today that ... Canaccord|Genuity Growth Conference in Boston, Massachusetts ... William C. Taylor , President and COO, and ...
(Date:8/3/2015)... 2015 E-QURE Corp. (OTCQB: EQUR), ... Bio-electrical Signal Therapy device ("BST Device"), a new and ... heal chronic wounds, today announced that the Company has ... distributor specializing in medical devices, for the marketing and ... a 70 years old, sales, marketing and distribution company ...
(Date:7/31/2015)... , July 31, 2015 In today,s ... that help them drive positive health outcomes, improve ... source of patient care in their communities. At ... tradeshow and conference, AmerisourceBergen announced a new set ... Services Administration Organization and help independent pharmacies endure ...
Breaking Biology Technology:FamilyCord Announces Acquisition of LifeLine Cryogenics 2MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3
... a year and a half, cells from pigs are to be ... ... The Lions Clubs of Multiple,District 5M (MD5M) recently declared its ... expedite the,affordable and widespread availability of pig donors of islet tissue ...
... Less Potential for ... SAN DIEGO, July 29 Orexigen(R) Therapeutics,Inc. (Nasdaq: ... Patent and,Trademark Office (USPTO) issued a Notice of Allowance ... a pharmaceutical,composition of zonisamide in combination with a series ...
... Mass., July 29 Inverness Medical,Innovations, Inc. (Amex: ... today announced its financial results for the quarter,ended June ... the Company recorded net revenue of,$401.1 million compared to ... 2007. The revenue increase was primarily due to increased,product ...
Cached Biology Technology:Spring Point Project Gains Support of Lions Clubs 2Spring Point Project Gains Support of Lions Clubs 3OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003 2OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003 3OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003 4Inverness Medical Innovations Announces Second Quarter 2008 Results 2Inverness Medical Innovations Announces Second Quarter 2008 Results 3Inverness Medical Innovations Announces Second Quarter 2008 Results 4Inverness Medical Innovations Announces Second Quarter 2008 Results 5Inverness Medical Innovations Announces Second Quarter 2008 Results 6Inverness Medical Innovations Announces Second Quarter 2008 Results 7Inverness Medical Innovations Announces Second Quarter 2008 Results 8Inverness Medical Innovations Announces Second Quarter 2008 Results 9Inverness Medical Innovations Announces Second Quarter 2008 Results 10Inverness Medical Innovations Announces Second Quarter 2008 Results 11Inverness Medical Innovations Announces Second Quarter 2008 Results 12Inverness Medical Innovations Announces Second Quarter 2008 Results 13Inverness Medical Innovations Announces Second Quarter 2008 Results 14Inverness Medical Innovations Announces Second Quarter 2008 Results 15Inverness Medical Innovations Announces Second Quarter 2008 Results 16
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, 2015 /PRNewswire/ ... human interface solutions, announced today that it will report ... 2015 on Thursday, July 30, 2015 after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... Calif.) Sensors made from custom DNA molecules could be ... stem cells, according to an international team of researchers led ... Rome Tor Vergata. The new nanosensors can quickly detect ... as the master control switches of life. The research is ...
... series of research flights from the Arctic to the ... gases and particles in the atmosphere, scientists announced today. ... enabling researchers to generate the first detailed mapping of ... Earth,s climate. The series of flights, which come ...
... new way to detect the activity of proteins that bind ... genes in ways that make cells do everything from growing ... Journal of the American Chemical Society . Kevin ... percent of the 25,000-30,000 genes in the human body contain ...
Cached Biology News:Nanosensors made from DNA may light path to new cancer tests and drugs 2Nanosensors made from DNA may light path to new cancer tests and drugs 3First global portrait of greenhouse gases emerges from pole-to-pole flights 2First global portrait of greenhouse gases emerges from pole-to-pole flights 3First global portrait of greenhouse gases emerges from pole-to-pole flights 4
HSV 1 IgM...
... choice of Printing Surface (3 glass slides coated with ... 1 silicon wafer coated with 1000 Angstroms of Gold ... PDMS Stamps (3 PDMS micropatterned stamps with series of ... 10 mm or 200 um x 10 mm lines, ...
XBP-1 (F-4)...
ECE-1 (H-60)...
Biology Products: